Protein Engineering Microbial Engineering Molecular Engineering Biohybrid Molecules Genomics Immunotherapy Gene Therapy Cell Engineering Molecular Tools Biomaterials Metabolic Engineering Cell Line Development Artificial Organs Insect Biotechnology Blood Substitutes Enzyme Engineering Artificial Chromosomes Microbiology Microbial Processes Biomimicry Human Development DNA Engineering Bacteriophages DNA Technology Protein Design Biosecurity DNA Products DNA Synthesis Biosensors
Stronger 2026 guidance alongside a slight EPS miss drove a sharp share pullback.